Michael Gilbertson

Michael Gilbertson is a male doctor who helps people with different types of lymphoma, which are cancers that affect the immune system. Some of the specific lymphomas he works with include B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Non-Hodgkin Lymphoma.

Michael Gilbertson uses special skills and treatments to help his patients. He is known for his expertise in Bone Marrow Transplants, treating Burkitt Lymphoma, Classical Hodgkin Lymphoma, and other types of lymphoma. Patients trust him because he listens to them carefully and explains things in a way that is easy to understand.

To stay updated with the latest medical knowledge, Michael Gilbertson reads new research studies and attends conferences. This helps him provide the best care for his patients. He also works closely with other doctors and healthcare professionals to discuss cases and learn from each other.

One of Michael Gilbertson's notable publications is a study called "Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study." This study was published in a medical journal called Blood Advances. He is also involved in a clinical trial called "Frontline Treatment of Follicular Lymphoma with Atezolizumab and Obinutuzumab with and Without Radiotherapy."

Michael Gilbertson's work has had a positive impact on many patients' lives. His dedication to research and patient care has helped improve treatment options for people with lymphoma. Patients appreciate his compassion, expertise, and commitment to finding the best solutions for their health.

In summary, Michael Gilbertson is a caring and skilled doctor who specializes in treating lymphoma. He stays updated with the latest medical knowledge, collaborates with other healthcare professionals, and conducts research to improve patient care. His work has made a positive difference in the lives of many people facing lymphoma.